Hematology/Oncology

Top Story

One hour of physical activity offsets increased risk of death from sitting

July 29, 2016

About 60 to 75 minutes of moderate intensity physical activity negated the increased risk for death associated with sitting for 8 hours each day, according to findings published in The Lancet.

Ulf Ekelund, PhD, professor at the Norwegian School of Sport Sciences, in Oslo, and colleagues also reported that this level of activity mitigates, but does not completely offset, the increased risk for death associated with long periods of watching television.

In the Journals Plus

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016
Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer, according to a subgroup…
In the Journals Plus

Thyroid cancer risk increases with hysterectomy

July 29, 2016
Among postmenopausal women, the risk for thyroid cancer is increased with hysterectomy regardless of oophorectomy status, according to recently published data. Use of…

American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy

July 29, 2016
The American Society of Breast Surgeons issued a position statement that recommends against contralateral prophylactic mastectomy for average-risk women with unilateral…
In the Journals Plus

Ovarian cancer surveillance with CA-125 tests, CT scans common despite lack of proven benefit

July 29, 2016
Cancer antigen 125 tests and CT scans are routinely used for surveillance of patients with ovarian cancer despite a lack of proven benefit, according to results of a…
More News Headlines »
CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Video

VIDEO: Patient characteristics, tumor type play role in response to immunotherapy

July 15, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan